Improvement of dissolution rate of aceclofenac by solid dispersion technique

Powder Technology

Volumn 207, Issue 1-3, 2011, Pages 47-54

  Maulvi, Furqan A ^a   Dalwadi, Sonali J ^b   Thakkar, Vaishali T ^c   Soni, Tejal G ^c   Gohel, Mukesh C ^d   Gandhi, Tejal R ^c  

^a UKA TARSADIA UNIVERSITY   (India)

^b CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^c ANAND PHARMACY COLLEGE   (India)

^d L M COLLEGE OF PHARMACY   (India)

Author keywords

Aceclofenac; Avicel 200; Surface solid dispersion (SSD); Sylysia 350

Indexed keywords

ACECLOFENAC; AQUEOUS SOLUBILITY; AVICEL 200; CLASS II; DISSOLUTION PROFILES; DISSOLUTION RATES; FOURIER TRANSFORMATIONS; FTIR; IN-VITRO DISSOLUTION; PARTIAL INTERACTION; PHASE SOLUBILITY; PHOSPHATE BUFFERS; POORLY WATER-SOLUBLE DRUGS; SEM; SOLID DISPERSION; SOLID STATE CHARACTERIZATION; SYLYSIA 350; X-RAY DIFFRACTION STUDIES;

DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FOURIER ANALYSIS; FOURIER TRANSFORMS; INFRARED SPECTROSCOPY; POLYMERS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; X RAY DIFFRACTION;

DISPERSIONS;

ACECLOFENAC;

ARTICLE; CONCENTRATION RESPONSE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; SCANNING ELECTRON MICROSCOPY; SOLID STATE; WETTABILITY; X RAY DIFFRACTION;

EID: 78751584648     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2010.10.009     Document Type: Article

References (23)

1. Pharmacopoeia British The Stationary Office, MHRA 2005, Vol. 1. British Pharmacopoeial Commission office, London.
2. Parfitt K. Analgesics anti-inflammatory and antipyretics. Martindale: The Complete Drug Reference 1999, 2-12. Massachusetts. 32nd ed. J.E.F. Reynolds (Ed.).
3. Gowda K.V., Rajan D.S., Mandal U., Selvan P.S., Sam Solomon W.D., Bose A., Sarkar A.K., Pal T.K., Chattaraj T.K. Evaluation of bioequivalence of two formulations containing 100mg of aceclofenac. Drug Dev. Ind. Pharm. 2006, 32:19-25.
4. Gorden Amidon L., Loebenberga Raimar Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000, 50:3-12.
5. Lee B., Jung H. Enhanced bioavailability of poorly water-soluble aceclofenac using PEG-based solid dispersion in rats, beagle dogs and human subjects. Pharm. Sci. Suppl. 1999, 4:14-18.
6. Kim T., Shin J., Lee B. Enhanced dissolution and bioavailability of poorly water-soluble aceclofenac using solid dispersion system. Denver, Colorado, USA: AAPS, Annual Meeting 2001, 21-25.
7. Perrut M., Jung J., Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes Part I: micronization of neat particles. Int. J. Pharm. 2005, 288:3-10.
8. Goddeeris C., Coacci J., Van den Mooter G. Correlation between digestion of the lipid phase of SMEDDS and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from SMEDDS. Eur. J. Pharm. Biopharm. 2007, 66:173-181.
9. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50:47-60.
10. Sekigushi K., Obi N. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 1961, 9:866-872.
11. Van den Mooter G., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P., Kinget R. Physical stabilisation of amorphous ketconazole in solid dispersions with polyvinyl pyrrolidone K25. Eur. J. Pharm. Sci. 2001, 12:261-269.
12. Ford J.L. The current status of solid dispersions. Pharm. Acta Helv. 1986, 61:69-88.
13. Serajuddin Abu T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999, 10:1058-1066.
14. Lieberman H.A., Lachman L., Schwartz J.B. Pharmaceutical Dosage Forms: Tablets 1989, Marcel Dekker, New York. 5th edition.
15. Moneghini M., Voinovich D., Perissutti B., Princivalle F. Action of carriers on carbamazepine dissolution. Pharm. Dev. Technol. 2002, 7:289-296.
16. Mutalik S. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies. Pak. J. Pharm. Sci. 2007, 3:218-226.
17. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 1965, 4:117-210.
18. Mukne A.P., Nagarsenker M.S. Triamterene β cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS 2004, 5:19-24.
19. Costa Paulo Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13:123-133.
20. Patel H.M., Shah S.A., I. Preparation and characterization of etoricoxib β cyclodextrin complexes prepared by the kneading method. Acta Pharm. 2007, 57:351-359.
21. Moore J.W., Flanner H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 6:64-74.
22. Soni Tejal G. Development of discriminating method for dissolution of aceclofenac marketed formulations. Dissolution Technol. 2008, 15:31-35.
23. Babu G.V.M.M., Prasad C.D.S., Murthy K.V.R. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water soluble drug nimodipine. Int. J. Pharm. 2002, 234:1-17.